A podcast on The End of Medicine with Podtech.net's John Furrier (available via iTunes as well):
Analyst, Investor and Silicon Valley Guru, Andy Kessler on the “End of Medicine". Andy Kessler, the guy behind the books Wall Street Meat and Running Money, just published a new book End of Medicine. Andy, who has been a wildly successful analyst and investor can smell the trends and in his new book. He declares the next major bubble and innovation boom from Moore’s Law - Medicine. PodTech’s John Furrier sat down with Andy at his Silicon Valley home to talk candidly about his book and his views on the “end of medicine”. Andy delares in this podcast: “What technology did for businesses will happen in Medicine”….”where the ATM machine replaced the bank teller… the same will happen to the medicine industry…very soom (if not already) a computer will replace your doctor.” In terms of “innovation in medicine”, Silicon Valley is leading the way and with that some big wealth creation opportunities. Andy’s right-on and has some great stories from his travels in researching the End of Medicine.
Computers can definitely help. But so will genomics. Knowing even a single disease-causing gene may extend lifespan by ~5 years (1-5). One minor corrollary may be a general viral antidote (6), useful for killer viruses like West Nile (5) and avian influenza ("bird flu").
We're now trying to find the genetic variations, called single nucleotide polymorphisms (SNPs, pronounced "snips"), for cancer. So far, we can predict who will get breast, colon, lung, ovarian, pancreatic, and prostate cancer among Caucasians with 85% accuracy. We'd like to extend this to >95% of all cancers, in all ethnic groups, and in children as well as adults.
Dave Moskowitz MD
CEO & Chief Medical Officer
GenoMed, Inc.
www.genomed.com
GMED.PK on the OTC Pink Sheets
Refs.
1-5: papers #1-4 and #6 at: http://www.genomed.com/index.cfm?action=investor&drill=publications
6: See GenoMed's proprietary approach to most viruses in Section 2151 of the Project BioShield II Act of 2005 (http://www.govtrack.us/congress/billtext.xpd?bill=s109-975), reproduced below:
CHAPTER 5--REPORT AND
13
ADMINISTRATION
14
15 SEC. 2151. REPORT TO CONGRESS.
16 Not later than 180 days after the date of enactment
17 of this Act, the Director of the Centers for Disease Control
18 and Prevention, in consultation with the Assistant Sec-
19 retary for Medical Readiness and Response of the Depart-
20 ment of Homeland Security and the Director of the Na-
21 tional Institute for Allergy and Infectious Disease of the
22 National Institutes of Health, shall submit a report to
23 Congress that describes alternatives to traditional vaccines
24 and anti-viral therapeutics for viral diseases, including
25 negative immunomodulation compounds that partially
S 975 PCS
296
1 suppress a macrophage-dependent innate immune re-
2 sponse of an individual to viral pathogens, in order to de-
3 crease morbidity and mortality from an excessive immune
4 response.
Posted by: David Moskowitz MD FACP | July 13, 2006 at 08:09 AM